European Healthtech startup funding raised during H2 2020.
In H2 2020, 302 European Healthtech companies raised a combined €3.6B across 312 funding rounds, up 235.1% versus H2 2019. UK led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Freeline Therapeutics | Series C | Jul 2020 | €107M |
| Atai Life Sciences | Series C | Nov 2020 | €105M |
| Sophia Genetics | Series D+ | Sep 2020 | €94M |
| Vectivbio | Other |
15 exits · €1.4B disclosed.
| MYR GmbH | Acquisition | Oct 2020 | €1.1B |
| Nanox Imaging | IPO | Aug 2020 | €140M |
| Fiagon | Acquisition | Sep 2020 | €60M |
| Oni | Acquisition | Nov 2020 | €40M |
| Oct 2020 |
| €94M |
| Neogene Therapeutics | Other | Sep 2020 | €93M |
| Freeline Therapeutics | Series C | Jul 2020 | €71M |
| Lava Therapeutics | Series C | Sep 2020 | €70M |
| Melio | Series C | Sep 2020 | €68M |
| Pharvaris | Series C | Nov 2020 | €67M |
| Sight Diagnostics | Series D+ | Jul 2020 | €61M |
| Sight | Series D+ | Aug 2020 | €60M |
| Achilles Therapeutics | Other | Nov 2020 | €59M |
| Imcheck Therapeutics | Other | Sep 2020 | €54M |
| F2G | Other | Aug 2020 | €52M |
| WiThings | Series B | Jul 2020 | €51M |